CHARACTERIZATION OF HIV REVERSE TRANSCRIPTASES WITH TYR181-]CYS AND LEU100-]IIE MUTATIONS

被引:20
作者
ZHANG, H
VRANG, L
UNGE, T
OBERG, B
机构
[1] SBL,KAROLINSKA INST,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN
[2] UNIV UPPSALA,CTR BIOMED,DEPT MOLEC BIOL,S-75124 UPPSALA,SWEDEN
关键词
D O I
10.1177/095632029300400506
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two mutants of human immunodeficiency virus (HIV) reverse transcriptase (RT), Tyr181 to Cys and Leu100 to Ile, have been prepared and characterized by use of various inhibitors. As compared to wild type RT the mutant RT's had lower K(cat)/K(m) values. The K(m) values were lower with heteropolymeric than with homopolymeric template-primers. Inhibition by phosphonoformate was of mixed type with both wild-type and mutant RT's and the mutants were less sensitive to phosphonoformate than the wild type RT. The non-nucleoside RT inhibitors 9-Cl-TIBO and L-697,661 gave a non-competitive inhibition with respect to substrate of the wild type RT. The mutant RT's were inhibited at higher concentrations, showing a mixed type of inhibition with respect to substrate. ddGTP caused a competitive inhibition of wild type and mutant RT's with respect to substrate. RT preparations with different mutations are useful in rapidly characterizing the interaction between various inhibitors and HIV RT and thus facilitate the development of new inhibitors.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 39 条
[1]   POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY 5-ETHYL-6-PHENYLTHIOURACIL DERIVATIVES THROUGH THEIR INTERACTION WITH THE HIV-1 REVERSE-TRANSCRIPTASE [J].
BABA, M ;
DECLERCQ, E ;
TANAKA, H ;
UBASAWA, M ;
TAKASHIMA, H ;
SEKIYA, K ;
NITTA, I ;
UMEZU, K ;
NAKASHIMA, H ;
MORI, S ;
SHIGETA, S ;
WALKER, RT ;
MIYASAKA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2356-2360
[2]   ACTION OF PANCREATIC DNASE - REQUIREMENTS FOR ACTIVATION OF DNA AS A TEMPLATE-PRIMER FOR DNA POLYMERASE-ALPHA [J].
BARIL, E ;
MITCHENER, J ;
LEE, L ;
BARIL, B .
NUCLEIC ACIDS RESEARCH, 1977, 4 (08) :2641-2653
[3]   PURIFICATION, CHARACTERIZATION AND CRYSTALLIZATION OF RECOMBINANT HIV-1 REVERSE-TRANSCRIPTASE [J].
BHIKHABHAI, R ;
JOELSON, T ;
UNGE, T ;
STRANDBERG, B ;
CARLSSON, T ;
LOVGREN, S .
JOURNAL OF CHROMATOGRAPHY, 1992, 604 (01) :157-170
[4]   3'-SPIRO NUCLEOSIDES, A NEW CLASS OF SPECIFIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INHIBITORS - SYNTHESIS AND ANTIVIRAL ACTIVITY OF [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-XYLO AND RIBOFURANOSE]-3'-SPIRO-5''-[4''-AMINO-1'',2''-OXATHIOLE 2'',2''-DIOXIDE] (TSAO) PYRIMIDINE NUCLEOSIDES [J].
CAMARASA, MJ ;
PEREZPEREZ, MJ ;
SANFELIX, A ;
BALZARINI, J ;
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2721-2727
[5]   ANTIRETROVIRAL THERAPY - STRATEGIES BEYOND SINGLE-AGENT REVERSE-TRANSCRIPTASE INHIBITION [J].
CONNOLLY, KJ ;
HAMMER, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :509-520
[6]   ANTIRETROVIRAL THERAPY - REVERSE-TRANSCRIPTASE INHIBITION [J].
CONNOLLY, KJ ;
HAMMER, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :245-254
[7]   DIFFERENTIAL INHIBITORY EFFECTS OF TIBO DERIVATIVES ON DIFFERENT STRAINS OF SIMIAN IMMUNODEFICIENCY VIRUS [J].
DEBYSER, Z ;
DEVREESE, K ;
PAUWELS, R ;
YAMAMOTO, N ;
ANNE, J ;
DE CLERCQ, E ;
DESMYTER, J .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :1799-1804
[8]   AN ANTIVIRAL TARGET ON REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVEALED BY TETRAHYDROIMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE AND TETRAHYDROIMIDAZO-[4,5,1-JK][1,4]BENZODIAZEPIN-2(1H)-ONE-THIONE DERIVATIVES [J].
DEBYSER, Z ;
PAUWELS, R ;
ANDRIES, K ;
DESMYTER, J ;
KUKLA, M ;
JANSSEN, PAJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1451-1455
[9]   HIV INHIBITORS TARGETED AT THE REVERSE-TRANSCRIPTASE [J].
DECLERCQ, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :119-137
[10]  
DECLERCQ E, 1991, J ACQ IMMUN DEF SYND, V4, P207